Consumer in a Crunch? And “The Big Short’s” Steve Eisman on How He’s Positioned for the Rest of the Year 7/25/24

25 Jul 2024 · 44 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Summary: CNBC's "Fast Money" - Consumer in a Crunch? And “The Big Short’s” Steve Eisman on How He’s Positioned for the Rest of the Year (7/25/24)

Episode Overview The episode focuses on recent market trends affecting consumer discretionary stocks, specifically highlighting Lululemon's significant drop due to a product failure and overall market sentiment. Additionally, Steve Eisman from Neuberger Berman shares insights on the current market sell-off and his strategy for the remainder of the year.

Key Discussions

  1. Lululemon's Decline
  2. Stock Performance: Shares of Lululemon fell by 9%, reaching their lowest point since May 2020 after being downgraded by Citigroup, which slashed the price target by almost 30%.
  3. Product Issues: The company faced challenges with its breeze-through leggings, which received poor reviews and were subsequently removed from shelves.
  4. Analysts' Outlook:
  5. Concerns about the overall strength of the consumer market and declining discretionary spending were prevalent.
  6. Analysts from Cowan downgraded several brands, including Nike and Skechers, indicating a trend where Western brands are losing ground to local competitors in China.
  1. Consumer Sentiment
  2. Consumer Discretionary Sector: The sector is underperforming, highlighted by various companies within travel, retail, and leisure showing signs of weakness.
  3. Market Indicators: Despite a broader gain in the discretionary sector, it remains the second-worst performing sector in the S&P 500 for the year.
  4. Spending Habits: Consumers across all income segments are becoming more frugal and discerning in their spending habits, with indications of a shift toward discount retailers like Walmart.
  1. Steve Eisman's Insights
  2. Market Sell-off: Steve Eisman remarked that the recent sell-off was partly psychological, reflecting a rotation in market sentiment rather than a fundamental downturn.
  3. Consumer Spending: He noted slight declines in consumer spending and rising delinquency rates but did not see these as alarming yet.
  4. Investment Strategy: Eisman remains bullish on companies positioned to leverage artificial intelligence developments, emphasizing that many corporations are still in the early stages of adopting AI technologies.
  1. Broader Market Trends
  2. Economic Indicators: The episode discussed GDP growth of 2.8% in Q2, with questions around its sustainability given current consumer behavior.
  3. Analyst Perspectives:
  4. Despite Lululemon's share drop, many analysts retain a bullish outlook, indicating a potential rebound in the future.
  5. A significant portion of the analyst community still recommends buying the stock, reflecting a belief in its long-term viability despite short-term challenges.

Key Takeaways

  • Lululemon's Future: Analysts express mixed sentiments, recognizing the company's strong brand but highlighting execution issues that could hinder recovery.
  • Consumer Behavior: A general trend of frugality and selective spending among consumers could impact discretionary sectors moving forward.
  • Investment Strategy: A focus on AI and tech companies may present opportunities, while traditional retail names may continue to face headwinds.

Conclusion This episode of "Fast Money" provides a comprehensive look at the challenges and strategies within the consumer discretionary market, particularly through the lens of Lululemon's struggles, alongside broader market reflections by Steve Eisman. The discussions highlight critical insights into consumer behavior and investment strategies amidst changing economic conditions.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:02Live from the Nasdaq market site in the heart of New York City's Times Square, this is Fast Here's what's on tap tonight. Consumer crunch. Shares of Lululemon sinking to new multi-year lows and the discretionary sector touching its worst levels of the month. Is there relief in sight for the retail names or will this be a case of buyer's remorse? Plus, boosting profits. UnitedHealth has grown into a colossus in the insurance industry. And a new in-depth report from Stat News details how the company has cornered the market at the expense of patients. We dive in with one of the authors later this hour.

0:33And we've got part two of Big Short Week here in Fast Money. Neuberger Berman, Steve Eisman, will join us with his take on yesterday's sell-off and how he is positioning himself for the back half of the year. I'm Melissa Leak. I'm D-Lar from Studio B at the NASDAQ. On the desk tonight, Dan Nathan, Guy Dami, Tim Seymour, and Steve Grasso. We start off with shares of Lululemon in full downward dog today. Had to use that. Shares tumbling 9 % to their lowest level since May 2020 after analysts at Citigroup downgraded the stock from buy to neutral, slashing the price target by nearly 30%. The company also dealt a blow as it was forced to pull the hotly anticipated breeze-through leggings from its stores and website amid tepid reviews for the product.

1:15But it wasn't the only consumer name feeling the heat today. Analysts at Cowan cutting their targets on the slew of names from Nike and Skechers to Adidas and Ralph Lauren saying Western brands are losing their advantage over domestic names in China. While the consumer discretionary sector broadly managed to eke out a gain today, it has fallen sharply from its recent highs and is the second worst performing sector in the S &P 500 this year. Is there any reason to give this group the benefit of the doubt? Is there belief for a comeback? Can Lulu shares get off the mat, so to speak? That is clever.

1:47You did that on your own. There wasn't for you. First of all, you know, we give analysts a hard time when justified. But Randall Koenig at Jeffries on On June 6th,$240 price target. A lot of people said you're out of your mind. Look where the stock traded down. Well done by Jeffries, number one. Number two, no, not really. I mean, you haven't seen capitulation yet. And quite frankly, they are clearly challenged. And we talk about it all the time. When specialty retail, when margins start to change, and when you start to see the other side of this sort of growth curve, that's when things get really bad.

2:22So I still think there's more pain ahead. Yeah, not particularly useful call. If you think about it, the stock's down 5 % or so. Obviously, this accelerated things to the downside today. But I would actually expand it a little bit in consumer discretionary and some of the things that we've seen out of the airlines, some of these other travel stocks. If you look at Expedia, we've been talking about Starbucks. And Chipotle is down 30 % right now just in the last few weeks. So there seems to be some pressure on discretionary. And at this point, even the airlines. We're probably going to talk about them a little bit.

2:52Most of them are trading at 52-week lows. So some of the things that we're hearing out of these earnings are not great if you think about the back half of the year and really how much resilience this consumer has. That's one thing we kept on hearing all year long, how resilient the consumer is. If you look through the lens of the stock market right now, it doesn't appear to be. It's anticipating, it seems, something that is happening with the consumer, Tim. And the problems with Lulu really remind me at this point of Nike in terms of the innovation gap that it seems to be experiencing. you know, competitors out there opening up stores, just catty corner from the current stores right now.

3:25I mean, the breeze through was, you know, part of the innovation pipeline that was really touted in the first quarter conference call saying, you know, this is going to be the start of the innovation cycle for the second half of the year. And here they are pulling it. It got a 3.1 star review from 112 reviewers who bought this stuff. apparently an unseemly seam in the back. I'm going to footnote Guy Adami's joke there. I think you've got a dynamic here. As someone that's been short at different times, Nike and Lulu in the last 18 months, I just think consumer discretionary as a group had the greatest generational moment of COVID, athleisure picking up pace, innovation dynamics around the space, and I think pent up demand that we're not going to see again for a long time.

4:10And what it meant in terms of margins, and there's no question, Lulu's been an incredible brand story, and it probably will continue to be, although there is some concern about ubiquity here. I just, it doesn't change soon. And in fact, I think what we've seen with a handful of these names, Lulu is certainly poster child. This is a third leg down. In other words, we've had two decided legs already in a bunch of these names. Very fascinating to see what Deckers is doing in the after hours and obviously really kicking it after selling off also dramatically into numbers. Dan referenced the broader consumer stuff.

4:42We've heard from a lot of different places, whether it's luxury and LVMH, whether it's Comcast and theme parks really slowing, airlines, et cetera. You name it, we've heard about it. And I think it's just beginning, even though some of these stocks had priced a dramatic amount of this in. So back to Lulu, the question really is, especially with the breeze through, is how much of a successful launch was priced in by the analyst community? I think we're going to hear about that in the next few days and what that means for margin for a company that's gone into this downtrend in terms of peak margins.

5:13And that was part of the Jeffries argument three months ago, is that they go into this period where this is a stock that's at peak margin right now. What's really going to happen when they actually have to start discounting clear inventory, whether it's breeze through or, you know, tapered leg stuff. It's all about wide bottoms these days, apparently. There I go. I think wide bottoms are now on their way out. But we'll ask the analyst. You might know more about that than I do. Steve, you know, once upon a time, we were saying that the higher end consumer, the higher income household consumer would continue spending.

5:46They have the savings. They've got everything in place here to keep on spending. And yet we have heard, as Tim had mentioned, from every sort of income cohort, from many different brands across many different industries, that these are the very consumers that are being more thoughtful about how they spend and where they spend. These are the consumers who are migrating to Walmart for deals at this point. Yeah, you know, everybody wants to save a dollar. It doesn't matter what income bracket that you're in, but they're the last ones to fall, your high income earners. And it is about, you know, just to echo some of the things that have already been said, I think it's not a matter of the consumer failing as far as what they can afford.

6:27I think it's changing styles. I think it's lack of innovation. We've seen a designer leave or whatever, whatever the chief product officer leave. And city data that I'm looking at on my computer said spending for yoga and active apparel has been down. Now that has nothing to do with income levels. It's just a changing dynamic on what we, If you look at yoga pants, they range from in Lulu, they range from one hundred dollars to one hundred and forty dollars. You go to Athleta and you you wind up seeing the same stuff there for 70 to 90 dollars. So everyone wants to be frugal and especially in an unknown world where we don't know when the recession, if the recession is going to come.

7:14You want to be a little more frugal. And I think it's just changing designs. But Lulu, the bottom, in my opinion, is not in. So I concur with the rest of the group. It's interesting. I mean, this is Lulu specific without question. But I'll broaden it out and say I actually think it is a bit of a tell on the consumer. And you say, OK, guy, tell me why you think that. Why do you think that, guy? That's a great question, Mel, because look at MasterCard and Visa since March. Our crack staff and EC put up a MasterCard chart. By the way, reversed higher today, closed lower on today. So MasterCard and Visa have been telling their own story since early spring.

7:47and the story isn't particularly good. So when you overlay that on top of some of the commentary here from some of these retailers, look at how horrible the dollar stores have been trading, and then look at the strength of Walmart, and it all starts to make sense. The consumer is not in a good spot. Yeah, let me just say one thing really quickly. This morning we got this GDP print for Q2. It was much better than expectations. It was 2.8%. Guy, what percentage of GDP comes from the U.S. consumer? 70%, approximately 70%. Now listen, you might be able to explain away a little bit of that outperformance in the GDP, but there are definitely some cross currents as it relates to consumer.

8:20We just talked about luxury. We talked about, you know, the mid-end consumer. We talked about the low end. I mean, there's definitely headwinds here, but, you know, GDP might be saying something a little different. All right. Well, despite Lulu's 51 percent drop already this year, analysts are still broadly bullish on the name. 27 of the 38 analysts covering the stock have a buy or overweight rating. The average price target is almost$400. That's about 60 % above today's close. Our next guest is one of those buy rating analysts. She just lowered her price target this afternoon to 360 from 425.

8:51Let's brand BTIGs. Janine Stickter. Janine, great to have you with us. Thanks for having me. How do you view the breeze through, you know, rollback? I mean, on one hand, you can say, you know, Lulu wants to be very attentive to consumers. They want to learn from their mistakes and continue to innovate. And so it's a good thing. Or you can say, you know what? that just shows that Lulu has an execution problem. It's lacking in the innovation pipeline. It's pushing through products that consumers don't want. I think Lulu has an execution problem. And I think that's part of the reason why we believe this can be fixed.

9:24The bear narrative for this stock has been there's too much competition. We have Ollo and Viore and they're killing Lulu. What we think is actually happening is that Lulu is getting in their own way. When we initiated on this stock about two months ago, we conducted a survey and what we saw was there was really high purchasing intent for Lulu. And even with this breeze through launch, we saw that there was a really high anticipation of this launch. The consumer came out to buy it. The problem was when they actually tried it on. For the vast majority of people who tried this pant on, it did not look good on them, and they had to send it back.

9:52So this says that the consumer is there. They're willing to buy when the product is right, even at a high price, which we know is a high-priced product. But the company has to execute, and they've kind of been getting in their own way this whole time. So whose fault is it? I mean, how do we rectify the situation? Does it require a new CEO? I mean, How do we fix this problem? Yeah, I think if we look back, you know, when Sancho announced her departure a few months ago, that was viewed as a negative. Now we look back on that and say this was product that was conceived under her watch and potentially it was time for a change in leadership at the product level.

10:24What they've done there is they've actually removed that chief product officer role and they've taken out that bridge between creative, between merchandising and between the CEO. And the hope there is that it will just create better agility and allow them to execute more quickly, be a bit more nimble, and maybe remove some of these execution errors that it seems like are really uncharacteristic for the company, but seem to keep coming up time and time again. Janine, with your price target and your EPS outlook, I mean, you're basically slapping a growth multiple on a company seemingly that's on the other side of the growth narrative.

10:53Is that accurate, or do you think you're going to see that reacceleration? We're not assuming they get back to anywhere like they were even six months ago. If you think about the start of the year before we had this slowdown that we think was execution caused, this company was trading at over 30 times P.E. Now it's trading at, depending on what numbers you're looking at, a high team speed multiple. We're arguing that it can get back into kind of the low 20s range, which would be well below historical averages, well below what was just to start the year, but a recovery multiple that still says that there's growth and that this isn't a North American business that is going into perpetual decline.

11:25For Lulu to regain sales, Janine, where do those dollars come from? Do they come directly from aloe and viore in your view or elsewhere? I mean, I'm just trying to figure out how much of it is that competitive dynamic. And once a consumer goes across the street and falls in love with aloe, how likely are they to go back to Lulu when they've been missing on the fashion front for so long now? Yeah. And this is one interesting thing that we found in our initiation when we surveyed consumers and we looked at customer overlap data. Certainly aloe and viore are nibbling at the edges of growth. But what we found is that the overlap's a lot less than we expected.

11:57We think really where the share can come from is from the bigger players. You have Nike, who we know is struggling and has been struggling for a long time. And it seems like right now they're more focused on fixing their footwear than anything else. Under Armour, which is a multibillion-dollar women's business, they're going through a complete reset right now and kind of walking away from that business temporarily. Athleta, another billion-dollar business where it's gotten a little bit better in Q1 but still in general has been floundering. So there's bigger companies where they can take share from, even if you have smaller upstarts like Ollo and you are starting to nibble at the edges of growth.

12:27All right, Janine, going to leave it there. Thanks so much for your time. Of course. Thank you. Janine Stickter of BTIG. Tim, she just gave you a laundry list of these athletic wearmakers that are all having issues at this point. And I think there will be a time and it's not going to be when the economy is kicking it. There's going to be an opportunity where the multiples have gotten pretty cheap. And there are brands in here that are extraordinary brands. They are leaders. They are best in class. I worry a little bit about that Lulu brand. I don't think it's ever going to be as hot as it was and as exclusive as it was.

13:00But it really does get down to where you put that multiple. And as she said, now in kind of the low to mid 20s on a multiple, you've put a massive discount on where it was. I think they get cheaper, and I think they get cheaper because I think the consumer has stopped going as hard into some of these areas as we know. We've already heard that. The trends over the last couple months, and even if you bring it back to CMG and some of the restaurant stocks, they talked about how the trends for the last two months. We may be seeing this, and Bill Dudley, who was out there saying the Fed's behind the curve.

13:32I mean, we have this debate every night on this show. There certainly has been an extended period of resilience. it does appear from this earnings season based upon real and current trends that we've seen from companies that it's happening faster. I don't think you need to chase any of these names here. And I think even Decker's, which had good numbers, is going to trickle lower again. I mean, to your point, Dan, in terms of putting together all the data points, the consumer is also slowing down their spending and experiences. At one point, it was a tradeoff, right, between stuff and experiences.

14:00And now it's just, you know what, I'm just not going to buy as much period across the board. Well, that was the thing during COVID, right? It went from goods and then after COVID, it went to services. So we're seeing a little bit of a hangover. We saw that in goods maybe a year, year and a half ago. But I would also mention that, you know, Royal Caribbean, you know, they gave slightly disappointing earnings. So the parks business, you know, we heard it from Comcast. I think we're probably going to hear it from Disney in the next few weeks. So it just kind of speaks to a consumer that is probably getting a little tapped at a time where credit got a lot harder to come by.

14:29And we know that some of those credit numbers, we've seen it in auto delinquencies, which are ticking up. So you put all that together and you say you see a consumer that's strained. And you can just throw a dart at the different companies that are suggesting that the back half of the year, again, is going to be more difficult than the first half. All right. Meantime, Alphabet shares taking another leg lower this afternoon after news OpenAI is launching its own search engine. Steve Kovac is here on set to break it all down for us. Hey, Steve. Hey, Mel. Yeah. So OpenAI is getting into the search business, and that sent Google shares down about 3 % today.

14:59And look, here's what the announcement is. It's called SearchGPT, brilliant name there, search engine, powered by OpenAI's AI models. They're calling it a prototype for now. It's not really launching yet, but you can sign up for a wait list to try it. OpenAI says it's partnering with publishers to give them proper credit in searches, also partnering with outlets like The Wall Street Journal and The Atlantic. And it's very similar to the popular search engine Perplexity. That's another hot AI startup backed by names like Jeff Bezos. By the way, OpenAI CEO Sam Altman, he tweeted that this will eventually integrate into the main ChatGPT app.

15:35So this is an experiment right now. They're going to learn from it and then eventually incorporate it into their main product. And the reaction to Alphabet shares that we saw, well, look, put that in context here, because Microsoft's Bing chat, which was announced, oh, I don't know, 18 months or so ago, really failed to gain share from Google. Despite the fact Microsoft said, you know, for every point of market share we gain against Google, we're going to make a billion dollars in ad revenue. That never happens. So it's way too early to tell guys if this is much of a threat to Google. But the market seems to think at least it's time to take three points off of Alphabet.

16:08I mean, it is amazing how the market assumes that whatever competitor comes in. So in terms of Microsoft and the failure of Bing to gain traction, do you think it's just because people didn't like Bing to begin with? And people didn't want to go back to Bing because they thought, you know, that wasn't a good search engine to begin with. There's part of it. But also just think of the distribution power Google has. It is the default search engine on the iPhone on pretty much every browser you get, Firefox, whatever, obviously Chrome. So they have that. They pay gazillions of dollars every quarter just to have that right to be right front and center.

16:40And Bing doesn't necessarily do that. They would like to be in that position, but they're not. And that is a huge barrier that a company like OpenAI would have to, if it is going to take on search. I think this is different, though, not a pure search play, because hearing Altman say we're going to incorporate this into the main ChatGPT app, this is just adding to what ChatGPT can do. It can pull from the web. It can tell you more current information. ChatGPT can't really do that now. Yeah, it's interesting. So I read what you read, Steve, and the idea that it will be integrated in ChatGPT that is a subscription product.

17:13You pay$20 a month for that. A few months ago, we had the CEO of Perplexity on here, and he's calling what they do an answer engine. And when you think about this, and I pay for it, I really like it, they give you the opportunity to use ChatGPT if you want, Claude from Anthropic, Llama from Meta. And then they're building their own large language model. And as I think about these, they're all becoming commoditized. Some of the smartest people in the business are suggesting that. So perplexity offers a lot more options, let's say, if you're doing it from a subscription standpoint. So I think it's less of a challenge to Google right now.

17:45Does that make some sense? It absolutely makes sense. I don't see this as a pure search play. Perplexity is more of a straight up, we want to be, I know they call it an answer engine, but it is more directly going at Google. We have not seen perplexity eaten to Google's market share. It doesn't mean it won't. But look, Google has that dominant position just by being front and center in pretty much every web browser by default. That is their key moat right now. Right. Steve, thank you. Thanks. Steve Kovach. It's nice having Steve here. It's nice having people visit us. We like people. We like speaking to people.

18:16Anytime. He can't invite himself back. I mean, you can't invite yourself back. Oh, so now he's bored? I mean, but no, that's all right. I'll come the day you're not here. How about that? Alphabet was in a vulnerable spot after its earnings. With this news, it's even worse. We talked about that in the earnings. The setup did not look particularly good, turned out to be right. But we also pointed out, to go back to December and January, stock traded from 155 down to 130, pretty much in a straight line. That provided an opportunity. By the way, it happened in the fall as well. And you're on the verge of the same thing happening now.

18:47So you're looking for a place to buy Google here, not sell it. It's one of the few stocks in that universe you can still make a case on valuation. All right. Coming up, investors feeling the love for Southwest, even as the airline announced a major overhaul to the way it does business. Has the name been cleared for takeoff? Next. Plus, Eli Lilly losing ground. What is behind the recent weakness as the recently red-hot shares enter a technical correction? More Fast Money right after this. This is Fast Money with Melissa Lee. Right here on CNBC.

19:30Welcome back to Fast Money. Two airlines topping the tape today after earnings before the bell, American and Southwest, both beating EPS estimates. Southwest also announcing big changes to its business model. The company long known for its open boarding policy, which was terrible. We'll now assign seats and offer pricier options with extra legroom. The changes will require new cabin layouts that will need FAA approval. Southwest also launching overnight flights in the coming year. And in the last hour, activist investor Elliott Management, which announced a stake in the company earlier this month, said these initiatives are not enough and are still calling for a change in management.

20:06Tim, some interesting news out of the airline sector today. Yeah, 50 years with that seeding policy and one that I've never enjoyed either. I mean, it really does require someone sharpen their elbows a little bit as they're getting through there. I look at airline stocks. I consider them the best trading stocks in the market. You look at the Jets ETF, it's down about 14 percent. This was a very, very negatively revised guide coming into this. So this bar was as low as you could go. Therefore, I'm not all that impressed. I think they've guided for effectively the markets expecting third quarter losses.

20:41I think across the airline industry, we've had some pretty dour outlook, both in terms of pricing power and where third quarter volume will go. So that's a signal to me that at least it's not yet time to dip in, even though I don't think the market's going to give you that head sign that it's time to start buying airlines again. They will get oversold before they are worth stepping back in for. Yeah, oversold in Delta comes in a form like high thirds, 38.5, 39. That's been support a couple times. So, you know, we've come off from 54 or so, but it feels like there's still some room. And I'll just throw this out there.

21:14Is this about the seating? Yeah. Yeah. Because I went to the college in the 1980s, and there was an airline called People's Express, and it was the same stuff. You didn't get to see this. I mean, it was a full mad rush into the plane. It's like a bus, right? I mean, what are they? Seriously, this is what year is this? This Southwest airline, these people think that's a good idea? You should applaud them for finally abandoning this. No, no, no. Johnson move. Johnson? What does that mean? Look it up. We're up to go to the Urban Dictionary there. Steve Grasso, do you have a trade on airlines? Yeah, if you look at Southwest, let's forget the fundamentals for a second.

21:52If you look at the chart on it, a tremendous bullish engulfing candle. We've been talking about this in a lot of other names. It's an outside reversal day. As a matter of fact, every airlines, with the exception of United, had a outside reversal day. And the most impressive one on a chart was Southwest. So could they stagger a little bit here? Of course. But it looks like a defined trend line that is probably going to be broken and start moving higher. Wait, so you think they should stick with this open? No, no, no. They should have never had it in the first place. I mean, seriously, somebody thinks, you know what, that sounds like a good idea.

Read the full transcript

22:31Let people run onto the plane and try to find a place to sit. Knock each other down. Knock each other down. And then somebody gets there late, and I've got to sit in the middle. I've got to get between two rather large people. I mean, that's a good idea. I didn't mean to set this up. No, you got me upset. I just want to clarify. You just have to fly private, guy. Just fly private. I mean, if I was doing that, you wouldn't be seeing me here. I'm going to see him with these fast money. You're watching from the plane. None of us are ballers like that. All right, there's a lot more fast money to come.

22:58Here's what's coming up next. Shares of Eli Lilly and Novo Nordisk losing weight today as competition in the obesity space heats up. Is Viking Therapeutics emerging as a serious threat to the incumbents? We'll go inside the expanding battle for GLP-1 supremacy next. Plus, big short week rolls on with one of the traders who saw the 2008 financial crisis long before it happened. Steve Eisman is here with his take on the recent sell-off and where to put your money in the second half of the year. You're watching Fast Money, live from the NASDAQ market side in Times Square. We're back right after this.

23:48Welcome back to Fast Money. This year's two big weight loss drug winners continuing their recent pullback today. Eli Lilly and Novo Nordisk, both pulling back after rival Viking Therapeutics last night, said it was advancing its oral and injectable GLP-1 treatments in their clinical trials. Both stocks hit record highs in the last month but are in correction territory right now. Lilly has lost$120 billion in market cap from its highs. And, of course, you have to think of this whole rotation that's going on from sort of the so-called high flyers, richer valuation stocks, to the more value-oriented areas of the market.

24:19And this is getting swept up in addition to all these headlines about newer competitors entering the market. Tim has brought this up, the fact that, and Dan talks, but they are trading like technology stocks. And we've tried to say incorrectly for a period of time that Eli Lilly specifically was getting really expensive on a number of different metrics, not least of which their market cap compared to the earnings revenue that they're going to see next year, which is historic in terms of big cap pharma. It's getting a bit more reasonable now, but I don't see any compelling reason to go jumping into Lilly here ahead of earnings.

24:52And I think it's August 8th. So, unfortunately, I still think there's room to the downside here. Yeah, to your point, especially with the competition coming, and there's going to be pressure on pricing too, right? If you think about that, that's what happens when you have that sort of competition. But it's trading at 60 times this year's earnings and about 18 times sales. And that only comes down to, if you believe that the next year estimates are here, 47 times and about 14 times sales. So to me, I think to Guy's point, you kind of want to wait until this thing and they give this sort of guidance.

25:19And then a lot of these studies we've been talking about, this is not really that great, but you kind of get a sense that everybody wants to get in this space. So ultimately, you're going to discount some of these valuations. You're going to look and see what comes to market. The Viking study was pretty robust, although I agree with you. Some of the studies are like six patients that, you know, that's not even worth noting. But I feel like it feels like Lilly and Nova are just a headline away. They just need a headline about their latest weight loss drug that doesn't involve as much muscle mass loss as the original generation.

25:51And off to the races again, Tim. Yeah. Six Aussies, mate, I believe, was the last study that we were talking about. You know, it's a case where Lilly, though, will have the greatest period of EPS expansion in pharma history. They're going to go from 650 last year to 1350 to 1950 if you take kind of a consensus call on this. So the question is, what happens after 1950 and what happens on the competitive landscape? So that's absolutely been part of the price action. We know this has been a market price action that's been rewarding rotation out of higher multiple stocks into lower multiple stocks.

26:28By the way, really happening within health care. Look at Pfizer. Look at J &J. Look at BMY. You're seeing it within the pharma space, and I think that continues. So the dynamic to me is around the competitive landscape that still, I think, look, Lily is going to do what they're going to do. There's no question. But the question really is beyond two years. And I think right now competition is probably moving faster than the market knows. I own some Lily. I'd be cautious. Yeah. And you also own Viking, as you pointed out yesterday night. So you own some of the competitors. Grasso, you're in sort of the competitors also still.

27:07I've been in and out of some of the competitors. I'm not in it now. But if you look back on the chart on Lilly and Novo, going back just a handful of days ago, July 16th or 17th is when Roche came out with their early stage as well. And we've talked about that on the show. And that's where the both stocks, Lilly and Novo, started to fall off a cliff. And what's amazing to me is that if they are trading like tech stocks, you don't really see NVIDIA or you didn't see NVIDIA fall off a cliff with very small competitors. So the trade I would look at is the XBI, the small cap biotech, because if a lot of these names are potentially takeouts, that's where you want to be.

27:50All right, coming up, Ford having its worst day since 2008 after reporting a mixed bag of earnings last night. And it's not the only automaker struggling. what we learned about what has got these names hitting the brakes. But first, big short week continues here on Fast Money. Steve Eisman, one of the traders who spotted the 2008 financial crisis before it happened, will join us with his take on the market sell-off and positioning in the second half. Be back right after this. Missed a moment of Fast? Catch us anytime on the go. Follow the Fast Money podcast. We're back right after this.

28:32Welcome back to Fast Money. Stocks losing steam into the close, unable to launch a big rebound from yesterday's washout. The Dow gaining 81 points but finishing well off its highs. The S &P ending the day down half a percent and the Nasdaq tumbling nearly one percent. Real estate stock CBRE Group jumping double digits today after a strong earnings report. Morgan Stanley also initiating coverage, saying the company is well positioned in the commercial space. Meantime, energy stocks jumping even as crude hits a six-week low. The XLE and the OIH ETF both now positive for July. And cold storage company Lineage jumping more than 3 % in its NASDAQ debut, the company raising$4.4 billion in the largest IPO so far this year.

29:13And finally, look at this bloodbath. Medical device company Dexcom plunging more than 40 % right now after missing second quarter revenue estimates and lowering fiscal year guidance. The lowering in guidance is about by$25 million. You've got to wonder how much market cap is coming off the stock right now. He is known for betting against the housing market before the 08 financial crisis. We continue our big short week special with a CNBC exclusive interview. Steve Eisman is senior portfolio manager at Neuberger Berman. He joins us now. Welcome back, Steve. Always good to see you. Thank you. You weren't surprised by this sellout that we saw yesterday's session.

29:49You think I wasn't surprised? Who are you talking to? I was surprised. You were surprised. Yes. You didn't think that this rotation was sort of in the works? Look, rotations are always violent. They always catch everybody unawares. And it's not a fundamental correction. It's like a psychological rotation. People all of a sudden woke up to the fact, like, I want to own something else for a while. Uh-huh. I never can anticipate those things. Right. Do you think the psychological rotation, though, is something that will hold? Is this something worth investing around, this change in psyche? I don't trade.

30:25I just don't trade. I'm not particularly good at it. God bless people who are. I just like to hold stocks for a long time. It doesn't change in long term. I don't think fundamentals have really changed all that much. I mean, the only negative data point I would point to is consumer spending seems to have slowed a little bit on the margin, and delinquencies are up a touch. but nothing and probably the economy has slowed a little bit but I don't particularly find it any of that alarming. Steve it's interesting last time you hear it and I'm not putting words in your mouth so if I'm wrong just please correct me as is your want to do but you said basically 100 % certainty that candidate Trump would be president in November.

31:02Yes. Has anything changed over the last couple weeks because some of this market gyrations. Has anything changed politically? Is that what you're asking me? That's what I'm asking you. You haven't noticed? Will you stand by that or has this changed the calculus a little bit? I actually, well, if you go back to when I said it, I said it a month well before the debate. And so what I said back then was that what was going to happen was that the protesters were going to convene in Chicago and they would burn the American flag and they would burn the Israeli flag and they would say a lot of very not nice things and the whole country would be appalled.

31:37I think that part of my prediction will be a thousand times proven to be true, because you got a little preview of that yesterday when Prime Minister Netanyahu was speaking in Congress, and the protesters took over Union Station, and it got pretty ugly. They burned an American flag. They did graffiti over all these monuments. I think the protesters probably think, given how up in the air the Democratic Party is right now, and they probably think they have an ability maybe to influence things. If I thought, let's say, 2 ,000 people were going to be at the Democratic convention, it's going to be 50 ,000 people.

32:14I mean, I don't know, but it's going to be a lot of people. And I think it would be very ugly. And so that part of my prediction doesn't change at all. Steve, going back to the markets, you know, again, trying to call these sorts of moves is really tough to do. And, again, you're long over. Oh, I think it's impossible. Yeah. And, again, but, you know, you think AI has a lot of legs, right? Yes. And you've talked about it. You see it kind of seeping through a lot of different other industries. Much like last summer in July into Q2 earnings period, we saw a slowdown in the sentiment of that. Those stocks sold off.

32:43We're kind of in that same period right now. Almost to the day. Yeah. What do you think about the CapEx cycles? Because I believe NVIDIA started selling off when Google Alphabet's CapEx wasn't that much better than expected. So next week we have Microsoft and we have Meta, which are two big customers of NVIDIA. And so do you use these opportunities? Let's just say those stocks are down 25%, 30%. Are you adding to those positions there if you get these sorts of sell-offs? I mean, on sell-offs, if they're big enough, we probably would add. Let me give you a data point that tells me that we are so early in this AI story, it's hard to even tell where we are.

33:21So Accenture has two businesses. They have consulting business and they have the outsourcing business. And the consulting business is not doing particularly well, not badly but not well. But the outsourcing business is growing very rapidly. And the reason why it's growing very rapidly is companies all over the United States and in Europe are hiring Accenture to clean up their data. You have companies, major companies, that are not even in a position to do anything with an AI because their data is not yet clean and in one spot. So most of corporate America is just in the early process of cleaning its data before they can even figure out what to do with respect to AI.

33:57Snowflake is in that same business. And Snowflake has down 60-some percent from its highs and is trading near 52-week lows. So, again, I mean, there's kind of easy ways to kind of think about some of this stuff. But I could probably counter almost everything you say. Because unless you tell me that Microsoft, NVIDIA, all these companies are going to be$5 trillion companies, which I'm not sure they're going to be that anytime soon, I just think that there's a potential hangover for a lot of these stocks because a lot of the performance has been pulled forward. Well, I mean, you could have made the same argument last year, and then NVIDIA numbers exploded.

34:30So, look, I just think the AI story is early. What Microsoft is going to say, what NVIDIA is going to say, I have no idea. But the bottom line, it sounds like the pull-off that we saw, as terrible as it might have felt during the day. It felt bad. It felt bad. It's not a pull-back that you would buy. Did you add to positions based on... Well, we're fully invested. So, you know, can we do things on the margin? Sure. But, I mean, generally speaking, our clients are fully invested, and we've done pretty well, and we're not changing. The only reason why we would not be fully invested is because we think there's a recession coming, and that I don't see.

35:06Right. You do see, going back to the predictions in politics, a red sweep happening. That I don't know. You don't know. I still think I'm pretty certain that Trump will be president. I don't know whether it's going to be a complete red sweep or not. I find, if I may partificate for a moment, about what has just happened. One of my favorite shows in the world is The West Wing. And the last season, there's a wonderful scene, which I think is very pertinent to today, which is Jimmy Smits becomes the president-elect, but unfortunately his vice presidential candidate has died. And so he has to pick somebody.

35:46And so he has a conversation with Alan Alda, who's the guy that he beat. And he says to Alan Alda, I have a legal opinion that says that I can appoint anybody I want to be vice president. And the 583 electoral college members can vote for this person that becomes that person becomes vice president. What do you think? And Alan Alda says, this is the United States of America. You can't have 583 people nobody's ever heard of pick the vice president of the United States. It has to be an open process. Well, I'm not telling you to support Kamala Harris or not to support Kamala Harris, but she just got picked and completely not—the president of the United States just appointed her to run for president.

36:25And everybody's saying, okay. I find that very strange. I really do. And it says to me, more likely than not, that her support in the country is going to be a mile wide and an inch deep. Okay. Steve, always great to see you. You're always welcome whenever you want to come back. Oh, his jacket looks great. Your wife continues to do an amazing job. He says he picked it out himself. He's lying like a drug. Coming up, automakers on ice, a host of legacy auto names coming under serious pressure. After earnings, we'll dig into the drop and what it'll take to get the group revved up again next. And later, health insurer hang-ups, the author of a wide-ranging investigation, will join us to tell us how UnitedHealth could be profiting unfairly from its clinic acquisitions.

37:06More Fast Money in two.

37:17Welcome back to Fast Money. Ford shares plunging 18 % for their worst day in more than 15 years after the company's earnings report last night. The automaker missed profit estimates, maintained full-year guidance. Some investors were hoping forecasts would be hiked. Dodge and Jeep maker Stellantis also seeing shares drop after that company posted a nearly 50 % drop in profit for the quarter. We also seen the same story for Nissan. I mean, you named the automaker, Steve, and they're having troubles in the U.S. market. Yeah, there's nothing exciting about looking at these charts. And with Ford especially, there's a lot of technical damage that's done on a day like today.

37:53And think about it, a long piggybacking everything we heard about the warranty issues with Ford. Think about how much they lose on each EV. And the last thing is, when you really look at it, higher rates are not benefiting the automakers. So I'm not rushing into any of these. Tim? Well, I last night said pretty vociferously I thought it was overdone on Ford. I was wrong on that. But, you know, I'd rather focus on GM, who I thought numbers were fantastic. That's two quarters in a row they beat and raise. They've got a$10 billion buyback going on. They're going to – that will charge up EPS. I mean, it trades south of five times.

38:33And they are in growth areas in the global auto market. The U.S. pricing right now, for now, is also holding up. So I recognize, you know, GM's pullback is 11 % off of a massive, massive run. In fact, a chart that looks a lot like the MAG-7s. So I'm not that worried about the fundamentals there. And, you know, I realize there are things in the auto space that could come cyclically with the economy. But for now, the U.S. market is very strong for GM. Coming up, a new report shedding light on how UnitedHealth may be playing the system to boost profits. to the detriment of patients. We'll sit down with one of the authors for a closer look at the insurance industry and Medicare.

39:12That's next. More Fast Money in two.

39:20Welcome back to Fast Money, an in-depth report published today taking aim at the nation's biggest Medicare Advantage provider, UnitedHealth. The first investigation in a series by Stat News finding UNH is reaping profits through its giant network of physicians by over-diagnosing patients, resulting in massive sums of money that the company can then pay to itself. Joining us now is one of the article's authors, Bob Herman. Bob, great to have you with us. This is an extraordinary piece of work. I don't think many people understand how far the tentacles go in the health care industry of UnitedHealth.

39:52One in ten physicians are employed by UnitedHealth, effectively, and it's that leverage that they are really taking advantage of here. Can you sort of explain what you found? Because you interviewed so many physicians who are in this network. Yeah, thanks for having me, Melissa. UnitedHealth is known for being a large health insurance company, a large pharmacy benefit manager, but really this aspect of owning doctors, owning the medical clinics is really underappreciated. In terms of the physicians that it controls and it influences, it's one of the biggest now. If you own the doctor, you own a big part of the healthcare system.

40:32You get to control where the patient gets care, And crucially, you get to control the patient's medical record. You get to control how sick the patient might appear on paper. And that is so influential because it dictates, in this instance, it dictates how much United gets paid by Medicare. And, of course, that money is funded by taxpayers. So, specifically, you have talked to physicians who used to be employed by UnitedHealth, some currently employed, who feel pressure or felt pressure to code for certain conditions which they didn't even feel were applicable in that situation. So, effectively, UnitedHealth could get paid more.

41:11Is that right? That's right. Yeah. Physicians basically said after United came in and took over their medical practice, things changed. The first often was they commandeered their schedule where they had to see more patients. But what you're talking about is the bigger issue, which is they felt like there was pressure or an unspoken dictate to code more conditions for these patients. For example, we heard instances of United telling its doctors to code more for peripheral vascular disease, for chronic kidney disease. these types of conditions that are very lucrative if you put them down, but they're also open to interpretation.

41:54And patients might not even be getting treated for them. And so it's one of those things where if you control that coding process, you get to control how much money you get back. It's just shocking. Bob, unfortunately, we're out of time. I hope everybody out there reads this article, though. Bob Herman of Stat News. Appreciate it. Thanks for having me. Final trades.

42:30time for the final trade Tim guy nice sweep by the Mets in the Bronx last night selling this after hours pop and deckers. Steve. Sam Sarah, IOT, great trading name. Stock chart looks like an EKG. I'm currently long. Dan. Guy, these semis are hot to go. I'd be a seller SME. That's what I was doing. I was doing the hots to go. I'm sure all of our viewers knew that. Visteon, BC. Mad Money with Jim Cramer starts right now.

43:01All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC, NBC Universal, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such.

43:35To view the full Fast Money Disclaimer, please visit CNBC.com forward slash Fast Money Disclaimer.

From the publisher

Shares of Lululemon hit their lowest level in more than four years after a downgrade at Citi and trouble with one of its hotly-anticipated products. What its weakness says about the state of the consumer and how you should play the space. Plus in part two of our Big Short Week spectacular, Neuberger Berman’s Steve Eisman reacts to Wednesday’s sell-off and gives us his strategy for the back half of 2024.

 

Fast Money Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from CNBC's "Fast Money"

All 871 episodes
Consumer in a Crunch? And “The Big Short’s” Steve Eisman on How He’s Positioned for the Rest of the Year 7/25/24CNBC's "Fast Money" · 44 min
Listen in VO